Jing Lu

Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation.

Jianjun Yu, Yumin Dai, Janet Sim, 2013, Blood.

Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers

Audrey Kauffmann, Jianjun Yu, Yumin Dai, 2014, Clinical Cancer Research.